// App-Quantinova.ai

9546 : Trends in body mass index (BMI) during and after treatment for standard risk (SR) acute lymphoblastic leukemia (ALL): A report from the Childrens Oncology Group (COG).

Researchers

Presenter

  • Susan Joy Lindemulder

Principal Investigators

  • Linda C. Stork

  • Bruce C. Bostrom

  • Xiaomin Lu

  • Meenakshi Devidas

  • Joseph Philip Neglia

  • Nina Kadan-Lottick

Medical Centers

  • Children's Oncology Group, Gainesville, FL

  • Yale University School of Medicine, New Haven, CT

  • University of Minnesota, Minneapolis, MN

  • Children's Hospitals and Clinics of Minnesota, Minneapolis, MN

  • Oregon Health and Science University, Portland, OR

  • OHSU, Portland, OR

Locations

  • United States

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Acute lymphoblastic leukemia

Biomarkers

  • Body mass index

Drug/Treatment

  • Dexamethasone

  • Dekpak 13 Day Taperpak

  • Prednisone

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved